Proxy advisers ISS and Glass Lewis are urging investors to reject the plan at the September 9 annual meeting, according to ...

There's a provision buried in California's emissions rules that almost nobody outside a courtroom reads closely, and a class ...

Ocugen is maintained at a Hold rating due to mixed clinical progress and ongoing pivotal trials across its ophthalmology ...

ARM's revenue shows consistent year-over-year growth, although it fell sequentially in the second quarter. While ARM is known ...

The Xring O3’s multi-core score is massive. It stands at 14,350, which is higher than any other mobile chipset, including the ...

A study found evidence of face mites living on false lashes, as well as an increased risk of meibomian gland dysfunction.

A chemotherapy-free regimen offered durable disease control for certain patients with advanced breast cancer, according to results of the phase 1/phase 2 ASPIRE trial.The regimen — which consists of ...

Anthropic's model, according to the report released Wednesday, divides the future into three broad scenarios: modest, ...

UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest ...

Sony is undervalued, with its high-margin I&SS segment driven by secular growth and a robust competitive moat. Read why SONY ...

Multi-billion-dollar buildouts for AI partners, but an increasing number of food-stamp recipients among one's employees?

Compare vetted local installers, evaluate slope clearance requirements, and navigate Santa Clarita permits to secure your ...